Focus on Cancer

Focus on Cancer

Episodes

  • Testing to Trace Cancers of Unknown Primary Origin

    Jul 14, 2014 | 16 min
    Hosted by: Larry Kaskel Guest: F. Anthony Greco Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.
  • Lymphedema: The Untold Story After Mastectomy

    Jun 30, 2014 | 16 min
    Hosted by: Bruce Japsen Guest: Greg Brown For breast cancer patients, there is often an untold story after mastectomy and treatment. Greg Brown, chief executive officer of ImpediMed, tells host Bruce Japsen about how women can suffer a debilitating complication known as lymphedema and how test makers are moving to help diagnose the problem early.
  • Natural History of Breast Cancer: Early Detection vs. Mortality

    Jun 30, 2014 | 16 min
    Hosted by: Jennifer Shu Guest: Per-Henrik Zahl The widespread use of mammography to screen for breast cancer has resulted in an increase in breast tumor detection, as well as an increase in mortality rates associated with the disease. But the natural course of malignant diseases such as different types of cancer can vary considerably. Is it possible-even common-for some invasive breast tumors to regress without treatment? And if this is the case, how could this impact our strategies for screening, diagnosing and treating breast cancer? For more on these intriguing ideas, host Dr. Jennifer Shu welcomes Dr. Per-Henrik Zahl, epidemiologist and senior statistician at the Norwegian Institute of P...
  • Does Your Patient's Anxiety Point to Pancreatic Cancer?

    Jun 2, 2014 | 5 min
    Hosted by: Leslie P. Lundt Guest: Benjamin Griffith What is the connection between anxiety and pancreatic cancer? Certainly, patients can develop problems with anxiety after a cancer diagnosis. But pancreatic cancer seems to have the curious characteristic of anxiety as a presenting symptom. The age at which anxiety presents itself may be a clue as to whether you're looking at mental illness or a possible cancer diagnosis. Dr. Benjamin Griffith, assistant professor of medicine at the University of Virginia and the Edward Via Virginia College of Osteopathic Medicine, explains to host Dr. Leslie Lundt.
  • Breast-Conserving Surgery: Curative vs. Cosmetic Outcomes

    May 26, 2014 | 5 min
    Hosted by: Mark Nolan Hill Guest: Monica Morrow As we expand the scope of breast-conserving surgery for patients with breast cancer, have we focused too much on the cosmetic results, to the potential detriment of the oncologic outcome? It's a question that concerns some in the field of breast surgery, who believe the evidence to establish clinical efficacy for certain procedures is not yet in. Dr. Monica Morrow, chief of the breast service in the department of surgery, and the Anne Burnett Windfohr Chair of Clinical Oncology at Memorial Sloan-Kettering Cancer Center in New York, joins host Dr. Mark Nolan Hill to explore how we can address the potential pitfalls of emphasizing cosmesis in bre...
  • The Emerging Field of Clinical Cancer Genomics

    May 12, 2014 | 16 min
    Hosted by: Bruce Bloom Guest: William Foulkes The need to manage the health of patients with cancer, and at risk for developing cancer, has given rise to the field of cancer genomics. What is this field? What are the roles within the specialty? And how do they work with patients?Host Dr. Bruce Bloom talks with Dr. William Foulkes, director of the cancer genetics program at McGill University in Montreal, Canada.
  • Exploring the Molecular Origins of Breast Cancer

    May 12, 2014 | 15 min
    Hosted by: Lee Freedman Guest: Lajos Pusztai What does microarray-based gene expression profiling tell us in terms of diagnosing and treating breast cancer? How is this technology changing our perceptions of breast cancer? Dr. Lajos Pusztai, associate professor of medicine at the University of Texas M.D. Anderson Cancer Center, discusses some clinical applications of a multigene assay. Dr. Lee Freedman hosts.
  • State of Cancer Care in America from ASCO President Clifford Hudis, MD

    Apr 28, 2014 | 16 min
    Hosted by: Matt Birnholz Joining host Dr. Matt Birnholz is special guest, Dr. Clifford A. Hudis, President of the American Society of Clinical Oncology (ASCO) and Chief of the Breast Cancer Medicine Service and an attending physician at Memorial Sloan-Kettering Cancer Center. Dr. Hudis will provide an executive summayr of the recently released State of Cancer Care in America: 2014 report, which will help cancer care providers, policy makers, and others more effectively shape the future of cancer care during these uncertain times. Download and listen to this update! And, to learn more about the websites that Dr. Hudis references in this interview, please visit: State of Cancer Care in America...
  • Cancer and End-of-Life Issues in the Emergency Department

    Apr 28, 2014 | 15 min
    Hosted by: Shira Johnson Guest: Arthur Derse More than 500,000 Americans die from cancer every year, and many of those people spend their final hours in the emergency department. More and more patients and their families turn to ED doctors to help make difficult decisions when it comes to end-of-life issues. Dr. Arthur Derse, director of medical and legal affairs and associate director of the Medical College of Wisconsin's Center for the Study of Bioethics and professor of bioethics and emergency medicine, joins host Dr. Shira Johnson to look at how doctors can help terminally ill patients and their loved ones when it comes to living wills, life support and pain management.
  • What Advanced Practice Clinicians Need to Know About Diagnosing and Treating Breast Cancer

    Apr 28, 2014 | 16 min
    Hosted by: Mimi Secor Guest: Constance Roche It's estimated that one in eight women will be diagnosed with breast cancer in their lifetime. 75% of women who are diagnosed have no known risk factors. But the incidence and mortality rate of breast cancer has declined over the last couple of decades. The government released controversial amendments to screening recommendations last year based on mortality outcomes from breast cancer. What are the implications for our patients, and what screening guidelines should advanced practice clinicians recommend to patients? Nurse practitioner Constance Roche, a clinical coordinator at the Avon Comprehensive Evaluation Center in Boston, Massachusetts, joi...
  • Does Your Patient's Anxiety Point to Pancreatic Cancer?

    Apr 21, 2014 | 16 min
    Hosted by: Leslie P. Lundt Guest: Benjamin Griffith What is the connection between anxiety and pancreatic cancer? Certainly, patients can develop problems with anxiety after a cancer diagnosis. But pancreatic cancer seems to have the curious characteristic of anxiety as a presenting symptom. The age at which anxiety presents itself may be a clue as to whether you're looking at mental illness or a possible cancer diagnosis. Dr. Benjamin Griffith, assistant professor of medicine at the University of Virginia and the Edward Via Virginia College of Osteopathic Medicine, explains to host Dr. Leslie Lundt.
  • Genetic Research into Hypodiploid ALL

    Apr 21, 2014 | 12 min
    Hosted by: Bruce Bloom Guest: Charles Mullighan How does understanding the genetics of rare disease help us understand other pressing pediatric problems? Dr. Charles Mullighan is assistant member of the faculty, pathology department, St. Jude Children's Research Hospital. He joins Dr. Bruce Bloom to discuss the genetics of acute lymphoblastic leukemia.
  • Thriving Egg Business: Problems & Solutions

    Apr 21, 2014 | 16 min
    Hosted by: Maurice Pickard Guest: Laurie Zoloth Dr. Laurie Zoloth, director of the Northwestern University Center for Bioethics, Science and Society, talks about ovarian cryopreservation, maturation of oocytes in vitro, and politicized laboratory breakthroughs that were intended to meet the needs of female cancer survivors. She argues that we need to be prepared to deal with patients who will use the tools offered by oncofertility to delay childbearing, and meet the need for tissue in stem cell research. Hosted by Dr. Maurice Pickard.
  • Natural History of Breast Cancer: Early Detection vs. Mortality

    Apr 14, 2014 | 16 min
    Hosted by: Jennifer Shu Guest: Per-Henrik Zahl The widespread use of mammography to screen for breast cancer has resulted in an increase in breast tumor detection, as well as an increase in mortality rates associated with the disease. But the natural course of malignant diseases such as different types of cancer can vary considerably. Is it possible-even common-for some invasive breast tumors to regress without treatment? And if this is the case, how could this impact our strategies for screening, diagnosing and treating breast cancer? For more on these intriguing ideas, host Dr. Jennifer Shu welcomes Dr. Per-Henrik Zahl, epidemiologist and senior statistician at the Norwegian Institute of P...
  • A Way to Boost Cancer Cell Vulnerability to Chemotherapy

    Apr 14, 2014 | 15 min
    Hosted by: Bruce Japsen Guest: John Docherty Cancer cells can be made to become more vulnerable to treatments like chemotherapy, and there are therapeutics under development which are designed to impact this so-called microenvironment of tumor cells. John Docherty, president of Toronto-based Helix BioPharma, tells host Bruce Japsen about a new wave of treatments and therapies in the biotechnology industry that could better target cancer cells and in turn help patients deal with the side effects of chemotherapy.

Chat About This Show